MEDICAL FLUID DELIVERY DEVICE PROGRAMMING

• US 20120209241A1
• Filed: 01/25/2012
• Published: 08/16/2012
• Est. Priority Date: 02/10/2011
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Drew, Touby A.
• Granted Patent: US 10,719,584 B2
• Time in Patent Office: Days
• US Class Current: 604/500
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2202/0464 Cerebrospinal fluid
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/16831 Monitoring, detecting, signalling or eliminating infusion flow anomalies low-level float-valves causing cut-off A61M5/40; indicating or recording presence, absence or direction of flow in general G01P13/0066
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

In some aspects, systems, devices, and techniques for programming a medical fluid delivery device are described. In one example, the disclosure relates to a system including a medical fluid delivery device configured to deliver a therapeutic agent to a patient, and a processor. The processor may be configured to receive a proposed therapy dosing program that defines a fluid therapy for delivery to a patient via a medical fluid delivery device for a first period of time, determine a total dosage over a second period of time, where the second period of time at least partially overlaps the first period of time, and compare the total dosage over the second period of time to a reference dosage.

Claims

1. A method comprising:

receiving a proposed therapy dosing program that defines a fluid therapy for delivery to a patient via a medical fluid delivery device for a first period of time;

determining, using one or more processors, a total dosage over a second period of time, wherein the second period of time at least partially overlaps the first period of time; and

comparing the total dosage over the second period of time to a reference dosage.

2. The method of claim 1, further comprising determining whether to apply, based on the comparison, the proposed therapy dosing program to control therapy for delivery to the patient via the medical fluid delivery device based on the comparison.

3. The method of claim 2, further comprising delivering, after applying the proposed therapy dosing program, a therapy to the patient via the medical fluid delivery device, wherein the therapy is delivered to the patient according to the proposed therapy dosing program.

4. The method of claim 1, further comprising presenting an indicator indicative of the comparison via a user interface.

5. The method of claim 4, wherein the reference dosage comprises a reference dosage range, and wherein comparing the total dosage over the second period of time to the reference dosage comprise determining whether the total dosage is within the reference dosage range.

6. The method of claim 5, wherein the indicator indicative of the comparison via the user interface comprises an indicator indicative of whether the total dosage is within the reference dosage range.

7. The method of claim 1, further comprising rejecting the proposed therapy dosing program based on the comparison.

8. The method of claim 1, further comprising:

receiving, following the comparison, a modification to the proposed therapy dosing program;

determining, using the modified proposed therapy dosing program, a total dosage over the second period of time; and

comparing the total dosage over the second period of time to the reference dosage.

9. The method of claim 1, wherein a duration of the second period of time is less than a duration of the first period of time.

10. The method of claim 1, further comprising:

determining a total dosage over a third period of time, wherein the third period of time at least partially overlaps the first time period; and

comparing the total dosage over the third period of time to a reference dosage for the third period of time.

11. The method of claim 10, wherein a duration of the third period of time is different than a duration of the second period of time.

12. The method of claim 1, wherein the proposed therapy dosing program includes a therapy schedule defining rate and duration for delivery of a therapeutic agent during the first period of time.

13. The method of claim 1, wherein the proposed therapy dosing program comprises a first proposed therapy dosing program that defines fluid therapy for delivery to the patient via the medical fluid delivery device for the first period of time, the method further comprising receiving a second proposed therapy dosing program that defines fluid therapy for delivery to the patient via the medical fluid delivery device for a third period of time, wherein the second period of time overlaps a portion of the first time period and a portion of the third time period.

14. The method of claim 1, wherein determining the total dosage over the second period of time comprises determining a total dosage for each of a plurality of second periods of time, wherein the plurality of second periods of time, in combination, include substantially all of the first time period, and

wherein comparing the total dosage over the second period of time to a reference dosage comprises comparing the total dosage for each of the plurality of second periods of time to the reference dosage.

15. A system comprising:

a medical fluid delivery device configured to deliver a therapeutic agent to a patient; and

a processor configured to receive a proposed therapy dosing program that defines a fluid therapy for delivery to a patient via a medical fluid delivery device for a first period of time, determine a total dosage over a second period of time, wherein the second period of time at least partially overlaps the first period of time, and compare the total dosage over the second period of time to a reference dosage

16. The system of claim 15, wherein the processor is configured to determine whether to apply the proposed therapy dosing program to define therapy for delivery to the patient via the medical fluid delivery device based on the comparison.

17. The system of claim 16, wherein the processor is configured to, after applying the proposed therapy dosing program, control delivery of therapy to the patient via the medical fluid delivery device, wherein the processor controls the delivery of the therapy to the patient according to the proposed therapy dosing program.

18. The system of claim 15, further comprising a user interface, wherein the processor is configured to present an indicator indicative of the comparison via the user interface.

19. The system of claim 18, wherein the reference dosage comprises a reference dosage range, and wherein the processor compares the total dosage over the second period of time to the reference dosage by at least determining whether the total dosage is within the reference dosage range.

20. The system of claim 19, wherein the indicator indicative of the comparison via the user interface comprises an indicator indicative of whether the total dosage is within the reference dosage range.

21. The system of claim 15, wherein the processor is configured to reject the proposed therapy dosing program based on the comparison.

22. The system of claim 15, wherein the processor is configured to:

receive, following the comparison, a modification to the proposed therapy dosing program;

determine, using the modified proposed therapy dosing program, a total dosage over the second period of time, wherein the second period of time at least partially overlaps the first time period; and

compare the total dosage over the second period of time to the reference dosage.

23. The system of claim 15, wherein a duration of the second period of time is less than a duration of the first period of time.

24. The system of claim 15, wherein the processor is configured to:

determine a total dosage over a third period of time, wherein the third period of time at least partially overlaps the first time period; and

compare the total dosage over the third period of time to a reference dosage for the third period of time.

25. The system of claim 24, wherein a duration of the third period of time is different than a duration of the first period of time.

26. The system of claim 15, wherein the proposed therapy dosing program includes a therapy schedule defining rate and duration for delivery of a therapeutic agent during the first period of time.

27. The system of claim 15, wherein the proposed therapy dosing program comprises a first proposed therapy dosing program that defines fluid therapy for delivery to the patient via the medical fluid delivery device for the first period of time, wherein the processor is configured to receive a second proposed therapy dosing program that defines fluid therapy for delivery to the patient via the medical fluid delivery device for a third period of time, wherein the second period of time overlaps a portion of the first time period and a portion of the third time period,.

28. The system of claim 15, wherein processor determines the total dosage over the second period of time by at least determining a total dosage for each of a plurality of second periods of time, wherein the plurality of second periods of time, in combination, include substantially all of the first time period, and

wherein the processor compares the total dosage over the second period of time to a reference dosage by at least comparing the total dosage for each of the plurality of second periods of time to the reference dosage.

29. A system comprising:

means for receiving a proposed therapy dosing program that defines a fluid therapy for delivery to a patient via a medical fluid delivery device for a first period of time;

means for determining a total dosage over a second period of time, wherein the second period of time at least partially overlaps the first period of time; and

means for comparing the total dosage over the second period of time to a reference dosage.

30. A non-transitory computer-readable storage medium comprising instructions that cause one or more processors to:

receive a proposed therapy dosing program that defines a fluid therapy for delivery to a patient via a medical fluid delivery device for a first period of time;

determine a total dosage over a second period of time, wherein the second period of time at least partially overlaps the first period of time; and

compare the total dosage over the second period of time to a reference dosage.